Product Information
LEVOTHYROXINE 137 MCG TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.0630 per EA under NDC 68180097209. Its NADAC has been published 160 times since Jun 7, 2023.
Strength
.137 mg/1
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180097209
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LEVOTHYROXINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA209713On Market Since
3/20/2019
Pharmacological Classes
Price Statistics
The NADAC for LEVOTHYROXINE 137 MCG TABLET has been published 160 times since Jun 7, 2023, and over the history we have for it it has declined 48.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0630 per EA |
|---|---|
| All-time high | $0.1439 (Jul 12, 2023) |
| All-time low | $0.0555 (Jul 17, 2024) |
| 52-week high | $0.0767 |
| 52-week low | $0.0630 |
| Median price | $0.0767 |
| Average price | $0.0810 |
| Largest weekly change | +51.0% (Jun 19, 2024) |
| Weeks tracked | 160 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LEVOTHYROXINE 137 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 137 MCG TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.0630 per EA (NDC 68180097209), effective Jun 24, 2026.
How has the price of LEVOTHYROXINE 137 MCG TABLET changed over time?
Over the history we have for it, the NADAC for LEVOTHYROXINE 137 MCG TABLET has declined 48.5%. It has been tracked across 160 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 137 MCG TABLET?
Since Jun 7, 2023, the NADAC for LEVOTHYROXINE 137 MCG TABLET has ranged from a low of $0.0555 (Jul 17, 2024) to a high of $0.1439 (Jul 12, 2023), with a median of $0.0767 per EA.
Are there cheaper alternatives to LEVOTHYROXINE 137 MCG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as LEVOTHYROXINE 137 MCG TABLET, but none are currently priced below it.
Who manufactures LEVOTHYROXINE 137 MCG TABLET?
LEVOTHYROXINE 137 MCG TABLET (NDC 68180097209) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification